SILENCE THERAPEUTICS PLC-ADR (SLN)

US82686Q1013 - ADR

21.99  +0.69 (+3.24%)

After market: 21.99 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
28.04M5.48M244.00K0.0016.00K
Cost Of Goods
12.83M3.76MN/AN/AN/A
Gross Profit
15.21M1.72MN/AN/AN/A
Operating Expenses
62.48M37.56M22.98M20.57M14.41M
Research and Development
42.49M20.21M13.34M9.74M7.94M
Selling, General, and Administrative Expenses
19.99M13.98M9.64M10.83M6.46M
Operating Income
-47.27M-35.85M-22.73M-20.57M-14.39M
Interest Income/Expense
-3.13M-194.00K-136.00K45.00K10.66M
Other Income/Expense
N/AN/AN/AN/A-49.00K
Income Before Taxes
-50.39M-36.04M-22.87M-20.53M-3.77M
Income Tax
-7.78M-3.49M-3.29M-2.12M-2.16M
Net Income
-42.62M-32.55M-19.58M-18.41M-1.62M
EBITDA
N/A-35.35M-22.25M-20.17M-13.96M
 
Per Share Data
EPS Diluted Total Ops
-0.94-0.40-0.26-0.26-0.02
Non GAAP EPS
N/A-0.40N/AN/AN/A
 
Statistics
Gross Profit Margin
54.24%31.34%N/AN/AN/A
Profit Margin
-151.98%-594.03%-8025.41%N/A-10112.50%
Operating Profit Margin
-168.56%-654.26%-9317.21%N/A-89943.75%

All data in GBP

Charts